BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 20484897)

  • 1. Comparative outcomes between hemo- and peritoneal dialysis patients with acute intracerebral hemorrhage.
    Hsieh CY; Chen CH; Wu AB; Tseng CC
    Am J Nephrol; 2010; 32(1):31-7. PubMed ID: 20484897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mortality differences between hemodialysis and peritoneal dialysis among ESRD patients in Georgia.
    Tchokhonelidze I
    Georgian Med News; 2007 Feb; (143):27-30. PubMed ID: 17404434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of dialytic modalities on clinical outcomes in ESRD patients with familial Mediterranean fever.
    Sahin S; Sahin GM; Ergin H; Kantarci G
    Ren Fail; 2007; 29(3):315-9. PubMed ID: 17497446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Duration of end-stage renal disease and kidney transplant outcome.
    Goldfarb-Rumyantzev A; Hurdle JF; Scandling J; Wang Z; Baird B; Barenbaum L; Cheung AK
    Nephrol Dial Transplant; 2005 Jan; 20(1):167-75. PubMed ID: 15546892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comorbidity and its change predict survival in incident dialysis patients.
    Miskulin DC; Meyer KB; Martin AA; Fink NE; Coresh J; Powe NR; Klag MJ; Levey AS;
    Am J Kidney Dis; 2003 Jan; 41(1):149-61. PubMed ID: 12500232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Testing the outcome score of spontaneous intracerebral haemorrhage in haemodialysis patients.
    Huang BR; Lo YL; Chang CH; Chen TY
    Intern Med J; 2009 Oct; 39(10):692-5. PubMed ID: 19849758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The importance of serum albumin and phosphorous as predictors of mortality in ESRD patients.
    Phelan PJ; O'Kelly P; Walshe JJ; Conlon PJ
    Ren Fail; 2008; 30(4):423-9. PubMed ID: 18569917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perceived health-related quality of life and comorbidity in diabetic patients starting dialysis (CALVIDIA study).
    Martínez-Castelao A; Gòrriz JL; Garcia-López F; López-Revuelta K; De Alvaro F; Cruzado JM;
    J Nephrol; 2004; 17(4):544-51. PubMed ID: 15372417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal function and serum albumin at the start of dialysis in 514 Chinese ESRD in-patients.
    Liu H; Peng Y; Liu F; Xiao H; Chen X; Huang A; Liu Y
    Ren Fail; 2008; 30(7):685-90. PubMed ID: 18704816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peritoneal dialysis is the therapy of choice for end-stage renal disease patients with hereditary clotting disorders.
    Bajo MA; del Peso G; Jiménez V; Aguilera A; Villar A; Jiménez C; Selgas R
    Adv Perit Dial; 2000; 16():170-3. PubMed ID: 11045286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparison of clinical outcomes in peritoneal dialysis and hemodialysis].
    Roob JM
    Wien Klin Wochenschr; 2005; 117 Suppl 6():60-8. PubMed ID: 16437335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute pancreatitis in patients on chronic peritoneal dialysis: an increased risk?
    Quraishi ER; Goel S; Gupta M; Catanzaro A; Zasuwa G; Divine G
    Am J Gastroenterol; 2005 Oct; 100(10):2288-93. PubMed ID: 16181382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical outcomes after percutaneous coronary intervention with drug-eluting stents in dialysis patients.
    Hassani SE; Chu WW; Wolfram RM; Kuchulakanti PK; Xue Z; Gevorkian N; Suddath WO; Satler LF; Kent KM; Pichard AD; Weissman NJ; Waksman R
    J Invasive Cardiol; 2006 Jun; 18(6):273-7. PubMed ID: 16751681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical outcomes of intracerebral hemorrhage in hemodialysis patients.
    Sakamoto N; Ishikawa E; Aoki K; Uemae Y; Komatsu Y; Matsumura A
    World Neurosurg; 2014; 81(3-4):538-42. PubMed ID: 24141001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Chronic dialysis in advanced age patients: a reasonable therapeutic alternative?].
    Duclos J; Cubillos B; Salgado MC; Olea C; Casanova D
    Rev Med Chil; 1991 Nov; 119(11):1259-63. PubMed ID: 9723077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Muscle atrophy, inflammation and clinical outcome in incident and prevalent dialysis patients.
    Carrero JJ; Chmielewski M; Axelsson J; Snaedal S; Heimbürger O; Bárány P; Suliman ME; Lindholm B; Stenvinkel P; Qureshi AR
    Clin Nutr; 2008 Aug; 27(4):557-64. PubMed ID: 18538898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factors of spontaneous intracerebral haemorrhage in haemodialysis patients and predictors of 30-day mortality.
    Huang BR; Liao CC; Huang WH; Hsu YH; Hsu JC; Yen HC; Lin CL
    Intern Med J; 2008 Jul; 38(7):568-74. PubMed ID: 18028368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemodialysis versus peritoneal dialysis: a case control study of survival in patients with chronic kidney disease stage 5.
    Maier A; Stocks F; Pommer W; Zidek W; Tepel M; Scholze A
    Ther Apher Dial; 2009 Jun; 13(3):199-204. PubMed ID: 19527466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors affecting outcome of intracerebral hemorrhage in patients undergoing chronic hemodialysis.
    Ochiai H; Uezono S; Kawano H; Ikeda N; Kodama K; Akiyama H
    Ren Fail; 2010; 32(8):923-7. PubMed ID: 20722558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Superior outcome of nafamostat mesilate as an anticoagulant in patients undergoing maintenance hemodialysis with intracerebral hemorrhage.
    Yang JW; Han BG; Kim BR; Lee YH; Kim YS; Yu JM; Choi SO
    Ren Fail; 2009; 31(8):668-75. PubMed ID: 19814633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.